Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Free Radic Biol Med. 2010 Jun 1;48(11):1559-63. doi: 10.1016/j.freeradbiomed.2010.03.001. Epub 2010 Mar 6.
Geldanamycin (GM), a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anti-cancer properties. Because of its adverse effects on liver, its less toxic derivatives 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer. Previously, it has been demonstrated that the redox cycling of GM by NADPH-cytochrome P450 reductase leads to the formation of the GM semiquinone and superoxide radicals, the latter being identified using spin-trapping. We hypothesized that the different hepatotoxicity induced by GM, 17-AAG and 17-DMAG reflects the redox active properties of the quinone moiety and possibly the extent of superoxide formation, which may stimulate cellular oxidative injury. Our data demonstrate that superoxide can be efficiently trapped during the reduction of GM, 17-AAG and 17-DMAG by NADPH-cytochrome P450 reductase, and that superoxide formation rate followed the order 17-DMAG > 17-AAG > GM. In the absence of superoxide scavengers, the rate of NADPH oxidation followed the order 17-DMAG > GM > 17-AAG. The half-wave one-electron reduction potentials (E(1/2)) of GM, 17-AAG and 17-DMAG in DMSO have been determined to be -0.37, -0.13 and -0.015V (vs. Ag/AgCl), respectively. If the same order of E(1/2) follows in neutral aqueous media, thermodynamic considerations imply that 17-DMAG is more readily reduced by the P450 reductase as well as by superoxide. The order of the drug cytotoxicity toward rat primary hepatocytes, as determined by their effect on cell viability and on intracellular oxidant level, was opposite to the order of E(1/2) of the respective quinone/semiquinone couples. These results suggest that hepatotoxicity exhibited by the Hsp90 inhibitors belonging to benzoquinone ansamycins could be attributed to superoxide. The apparent discrepancy between the order of toxicity and the orders of superoxide formation rate, which is correlated with E(1/2), is discussed.
格尔德霉素(GM)是一种苯醌 ansamycin 抗生素,是 Hsp90 的天然产物抑制剂,具有强大而广泛的抗癌特性。由于其对肝脏的不良影响,其毒性较小的衍生物 17-(烯丙氨基)-17-去甲氧基格尔德霉素(17-AAG)和 17-(二甲基氨基乙基氨基)-17-去甲氧基格尔德霉素(17-DMAG)目前正在评估用于癌症治疗。以前已经证明,NADPH-细胞色素 P450 还原酶使 GM 的氧化还原循环导致 GM 半醌和超氧自由基的形成,后者使用自旋捕获来鉴定。我们假设 GM、17-AAG 和 17-DMAG 诱导的不同肝毒性反映了醌部分的氧化还原活性特性,并且可能反映了超氧形成的程度,这可能刺激细胞氧化损伤。我们的数据表明,超氧可以在 NADPH-细胞色素 P450 还原酶还原 GM、17-AAG 和 17-DMAG 期间有效地被捕获,并且超氧形成速率遵循 17-DMAG > 17-AAG > GM 的顺序。在没有超氧清除剂的情况下,NADPH 氧化速率遵循 17-DMAG > GM > 17-AAG 的顺序。在 DMSO 中 GM、17-AAG 和 17-DMAG 的半波单电子还原电位(E(1/2))分别为-0.37、-0.13 和-0.015V(相对于 Ag/AgCl)。如果在中性水介质中遵循相同的 E(1/2)顺序,则热力学考虑表明 17-DMAG 更容易被 P450 还原酶以及超氧还原。通过它们对细胞活力和细胞内氧化剂水平的影响来确定对大鼠原代肝细胞的药物细胞毒性的顺序与相应醌/半醌偶联物的 E(1/2)顺序相反。这些结果表明,属于苯醌 ansamycin 的 Hsp90 抑制剂表现出的肝毒性可归因于超氧。讨论了与 E(1/2)相关的毒性顺序和超氧形成速率顺序之间的明显差异。